Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Value Stock, Under Radar

390.8500 -2.80 (-0.71%)

NSE Jan 14, 2026 15:30 PM

30.71% Fall from 52W High

Volume: 51,848

Aarti Drugs Ltd.

30 Oct 2022

390.85

-0.71%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs Ltd. has an average target of 610.00 from 1 broker.